1.
Acta Academiae Medicinae Sinicae
;
(6): 278-282, 2019.
Artículo
en Chino
| WPRIM
| ID: wpr-776037
RESUMEN
Multi-target anticancer drugs have a more comprehensive and extensive range of action,and there is an uncertain risk in the combination of two drugs.A case of acute toxicity induced by erlotinib combined with cabozantinib is reported in this article.